BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12145843)

  • 1. [Hepatitis B vaccination. Advocating for a protection principle].
    Aron E
    Bull Acad Natl Med; 2002; 186(2):361-6; discussion 366-8. PubMed ID: 12145843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
    Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
    Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccine and risk of multiple sclerosis.
    DeStefano F; Verstraeten T; Chen RT
    Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
    Tosti ME; Traversa G; Bianco E; Mele A
    Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccination and French Society ten years after the suspension of the vaccination campaign: how should we raise infant immunization coverage rates?
    Balinska MA
    J Clin Virol; 2009 Nov; 46(3):202-5. PubMed ID: 19716764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?].
    Cabrera-Gómez JA; Echazabal-Santana N; García González L; Ramos Cedeño AM; Rodríguez Roque MO; López Hernández O; Cabrera Núñez JA; González De La Nuez J; Téllez L
    Rev Neurol; 2002 Feb 16-28; 34(4):358-63. PubMed ID: 12022053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.
    Begier EM; Langford CA; Sneller MC; Wise RP; Ball R;
    J Rheumatol; 2004 Nov; 31(11):2181-8. PubMed ID: 15517631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes.
    Ozakbas S; Idiman E; Yulug B; Pakoz B; Bahar H; Gulay Z
    Tissue Antigens; 2006 Sep; 68(3):235-8. PubMed ID: 16948644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute transverse myelitis secondary to hepatitis B vaccination].
    Iñiguez C; Mauri JA; Larrodé P; López del Val J; Jericó I; Morales F
    Rev Neurol; 2000 Sep 1-15; 31(5):430-2. PubMed ID: 11027094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against Hepatitis B: 20 years later].
    Vildozola H
    Rev Gastroenterol Peru; 2007; 27(1):57-66. PubMed ID: 17431429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a causal link between hepatitis B vaccination and multiple sclerosis?
    Monteyne P; André FE
    Vaccine; 2000 Apr; 18(19):1994-2001. PubMed ID: 10706960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccine and demyelination (cont'd).
    Prescrire Int; 1999 Apr; 8(40):52. PubMed ID: 10848063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination and the risk of multiple sclerosis.
    Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM
    N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis and hepatitis B vaccination: adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence.
    Comenge Y; Girard M
    Med Hypotheses; 2006; 66(1):84-6. PubMed ID: 16176857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation.
    Jefferson T; Traversa G
    J Med Virol; 2002 Jul; 67(3):451-3. PubMed ID: 12116044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B vaccine: a new force against pandemic diseases].
    Clements CJ; Kane M; Hu DJ; Kim-farley R
    Foro Mund Salud; 1990; 11(2):165-8. PubMed ID: 12179351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-component vaccines: new preparations. Simpler hepatitis B vaccination of infants.
    Prescrire Int; 2004 Apr; 13(70):50-3. PubMed ID: 15148970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.